30 Day Psychedelic Pharmacology Podcast - Day 25 Psychedelics in Oncology episode artwork

EPISODE · Jan 30, 2025 · 15 MIN

30 Day Psychedelic Pharmacology Podcast - Day 25 Psychedelics in Oncology

from Cannabinoid and Psychedelic Pharmacology and Drug Development

This podcast episode explores the therapeutic potential of psychedelics in oncology, particularly focusing on how substances like psilocybin and MDMA can help cancer patients manage existential distress and improve quality of life. The discussion covers key topics including:- The importance of set and setting in psychedelic therapy- The role of the 5-HT2A receptor in emotional regulation and fear processing- Clinical trials showing promising results in reducing anxiety and depression in cancer patients- Ethical considerations, including cultural sensitivity, access to treatment, and patient safety protocols

Episode metadata supplied by the publisher feed · Published Jan 30, 2025

Embed this episode

NOW PLAYING

30 Day Psychedelic Pharmacology Podcast - Day 25 Psychedelics in Oncology

0:00 15:09

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 15 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 30, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!